Neural Tube Defects
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
Neural tube defects (NTDs): CNS malformations due to abnormalities of neural tube closure during early embryonic development and include anencephaly, encephalocele, and spina bifida (SB)
- Open NTDs: Exposed neural tissue and membranes protrude through a bony defect and lack a skin covering.
- Due to failure of primary neural tube closure during the 3rd and 4th weeks after fertilization
- Include anencephaly, craniorachischisis, myelomeningocele, and myeloschisis
- Closed NTDs: theorized to be due to defects of secondary neurulation. Less common than open NTDs and are skin covered.
- Include some encephaloceles and various types of occult spinal dysraphism (OSD)
- Anencephaly: due to failed closure of rostral neural tube with total or partial absence of cranial vault and cerebral hemispheres
- Encephalocele: partial failure of rostral neural tube closure
- Abnormal brain tissue protrudes through a skull defect usually covered by skin.
- 70–80% are occipital, 20% are frontal.
- 10–20% of occipital defects are meningoceles and contain no brain tissue.
- SB: means “spine split in two” and includes open and closed types
- Myelomeningocele (MMC): open NTD of the spine, most common type of SB, and characterized by herniation of dysplastic spinal cord and meninges through a posterior vertebral column defect
- Closed SB: often not diagnosed at birth and often referred to as occult spinal dysraphism.
- Intact skin over the defect
- Wide spectrum of defects including lipomyelomeningocele, dermal sinus tracts, diastematomyelia (split cord malformations), myelocystocele, other tumors and cysts of the cord, and congenital spinal cord tethering
- NTDs affect ∼1 in 1,000 established pregnancies worldwide, with significant geographic variation.
- In the United States, birth prevalence has been decreasing due to periconceptional supplementation with folic acid as well as prenatal diagnosis and termination of pregnancy.
- CDC data from 2004 to 2006 showed 0.64 NTDs per 1,000 births (∼2,660 cases per year), with 54% classified as SB, 32% anencephaly, and 13% encephalocele.
Most NTDs are due to the interaction of genetic, environmental, and dietary risk factors.
- Variants of multiple genes probably confer some increased genetic susceptibility.
- Maternal nutrition and dietary factors
- Inadequate maternal folic acid intake
- Maternal diabetes mellitus
- Maternal obesity
- Maternal use of valproic acid (10× risk), carbamazepine, or alcohol during pregnancy
- Maternal exposure to hyperthermia during early pregnancy (e.g., sauna, hot tub, fever)
- In most NTD cases, a specific genetic cause is not found.
- Positive family history in ∼5% NTD cases
- After 1 child with an NTD, the recurrence rate is 2–5% for subsequent pregnancies.
- A chromosomal or cytogenetic abnormality in ∼10% of isolated NTDs, higher percentage in those with multiple congenital anomalies
- NTDs common in trisomy 13 and 18 and can be seen with duplications and deletions.
- Also seen as in single gene disorders or syndromes (e.g., Meckel, Waardenburg, 22q11 deletion syndromes)
- A number of candidate risk factor genes have been studied; the most implicated are those in the folate one-carbon metabolic pathway.
- A homozygous 677C>T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene in mother or child is associated with ∼1.8 times increased risk.
- Periconceptual folic acid supplementation has the potential to reduce NTDs by 50–70%.
- Because many pregnancies are not identified until after neural tube closure occurs, and because more than 50% of pregnancies are unplanned, the CDC recommends that all women of childbearing age receive a minimum of 0.4 mg (400 mcg) of folic acid daily.
- Women at high risk (prior pregnancy with NTD, on valproic acid, etc.) should take high-dose folic acid (4 mg daily), starting 1 month before and through the first 3 months of pregnancy.
- If taking valproic acid, consider switching to alternative medication during pregnancy.
Commonly Associated Conditions
- Open SB is virtually always associated with some malformation of the brain.
- Most children with MMC have a Chiari II (Arnold-Chiari) malformation, small posterior fossa with elongation of the cerebellum, and herniation through the foramen magnum.
- Chiari II malformation often causes obstructive hydrocephalus.
- Historically, about 80% of children with MMC required a CSF shunt.
- Callosal dysgenesis, cortical dysplasia, and subependymal heterotopias are also common.
- MMC is commonly associated with nonverbal learning disabilities and executive dysfunction.
- Open and closed SB: impairments directly due to spinal cord dysfunction:
- Paraparesis and sensory loss usually correlating with the level of the lesion
- Neurogenic bladder dysfunction
- Neurogenic bowel dysfunction
- Congenital foot deformities (club foot) and hip dysplasia are common with NTDs.